3-Hydroxy-3-methylgutaryl CoA reductase inhibitors, commonly referred to as the statins,
have proven therapeutic and preventative effects in cardiovascular diseases. Recently, there …

Importance For patients with cancer treated with palliative intent, quality of life (QOL) is a
critical aspect of treatment decision-making, alongside survival. However, regulatory approval …

Background Oral cavity and oropharyngeal cancers are frequently described as part of a
group of oral cancers or head and neck cancer. Treatment of oral cavity cancer is generally …

Chemotherapy-induced cardiotoxicity is a major cause of morbidity and mortality in cancer
survivors. It might manifest as arrhythmia, hypertension, myocardial ischemia, …

The relative survival benefits and postoperative mortality among the different types of neoadjuvant
treatments (such as chemotherapy only, radiotherapy only or chemoradiotherapy) for …

Background & Aims Hepatitis C virus (HCV)-related cirrhosis increases the risk for hepatocellular
carcinoma (HCC). After a sustained virologic response (SVR) to anti-HCV therapy, the …

Background: The late cardiac effect of adjuvant trastuzumab and its potential interaction
with anthracycline have not been well-studied on a population level. Methods: In this …

The popularity of handheld devices has created a flurry of research activity into new
protocols and applications that can handle and exploit the defining characteristic of this new …

Background: Resource and cost issues are a growing concern in health care. Thus, it is
important to have an accurate estimate of the economic burden of care. Previous work has …

Background Concurrent chemoradiotherapy followed by adjuvant chemotherapy (CRT-A) is
often the regimen of choice in locoregionally advanced nasopharyngeal carcinoma (NPC). …